Industrials [ 12/12 ] | Trading Companies & Distributors [ 62/74 ]
NYSE MKT | Common Stock
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease.
The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development.
The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023.
The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 12, 25 | -0.02 Increased by +77.78% | -0.03 Increased by +33.33% |
| Nov 7, 24 | -0.02 Increased by +60.00% | -0.03 Increased by +33.33% |
| Aug 7, 24 | -0.03 Increased by +25.00% | -0.03 |
| Jun 24, 24 | -0.40 Decreased by -427.01% | -0.04 Decreased by -900.00% |
| Feb 14, 24 | -0.09 Decreased by -112.26% | -0.04 Decreased by -125.00% |
| Nov 9, 23 | -0.05 Decreased by -6.84% | -0.05 |
| Aug 10, 23 | -0.04 Increased by +20.00% | - |
| Jun 30, 23 | -0.08 Increased by +41.62% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 257.00 K Increased by +25.98% | -1.83 M Increased by +67.28% | Decreased by -711.67% Increased by +74.02% |
| Sep 30, 24 | 412.00 K Increased by +41.58% | -1.72 M Increased by +29.95% | Decreased by -416.75% Increased by +50.52% |
| Jun 30, 24 | 272.00 K Decreased by -50.99% | -2.38 M Decreased by -14.60% | Decreased by -874.26% Decreased by -133.84% |
| Mar 31, 24 | 295.00 K Increased by +77.71% | -2.88 M Increased by +28.41% | Decreased by -977.97% Increased by +59.72% |
| Dec 31, 23 | 204.00 K Decreased by -38.55% | -5.59 M Decreased by -151.76% | Decreased by -2.74 K% Decreased by -309.72% |
| Sep 30, 23 | 291.00 K Increased by +44.06% | -2.45 M Decreased by -2.30% | Decreased by -842.27% Increased by +28.99% |
| Jun 30, 23 | 555.00 K Increased by +161.79% | -2.08 M Increased by +25.04% | Decreased by -373.87% Increased by +71.37% |
| Mar 31, 23 | 166.00 K Increased by +36.07% | -4.03 M Increased by +38.05% | Decreased by -2.43 K% Increased by +54.47% |